KRYS

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Krystal Biotech Inc

NASDAQ | KRYS

215.43

USD

$0.00

(

0.00%

)

At Close (As of Nov 28, 2025)

$6.34B

Market Cap

32.79

P/E Ratio

6.67

EPS

$221.84

52 Week High

$122.80

52 Week Low

HEALTHCARE

Sector

KRYS Chart

Recent Chart
Price Action

KRYS Technicals

Tags:

KRYS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $270M
Total Revenue $291M
Cost Of Revenue $20M
Costof Goods And Services Sold $20M
Operating Income $66M
Selling General And Administrative $114M
Research And Development $54M
Operating Expenses $205M
Investment Income Net -
Net Interest Income $30M
Interest Income $30M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.7M
Income Before Tax $95M
Income Tax Expense $6.2M
Interest And Debt Expense -
Net Income From Continuing Operations $89M
Comprehensive Income Net Of Tax -
Ebit $103M
Ebitda $110M
Net Income $89M

Revenue & Profitability

Earnings Performance

KRYS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.1B
Total Current Assets $742M
Cash And Cash Equivalents At Carrying Value $345M
Cash And Short Term Investments $345M
Inventory $27M
Current Net Receivables $105M
Total Non Current Assets $314M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $152M
Short Term Investments $253M
Other Current Assets $13M
Other Non Current Assets -
Total Liabilities $109M
Total Current Liabilities $102M
Current Accounts Payable $5M
Deferred Revenue -
Current Debt -
Short Term Debt $1.2M
Total Non Current Liabilities $7.5M
Capital Lease Obligations $7.3M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $7.3M
Other Current Liabilities $92M
Other Non Current Liabilities $1.4M
Total Shareholder Equity $946M
Treasury Stock -
Retained Earnings -$181M
Common Stock -
Common Stock Shares Outstanding $30M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $123M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $6.7M
Capital Expenditures $4.2M
Change In Receivables -
Change In Inventory -$12M
Profit Loss -
Cashflow From Investment -$163M
Cashflow From Financing $27M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $89M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $270M
Total Revenue $291M
Cost Of Revenue $20M
Costof Goods And Services Sold $20M
Operating Income $66M
Selling General And Administrative $114M
Research And Development $54M
Operating Expenses $205M
Investment Income Net -
Net Interest Income $30M
Interest Income $30M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.7M
Income Before Tax $95M
Income Tax Expense $6.2M
Interest And Debt Expense -
Net Income From Continuing Operations $89M
Comprehensive Income Net Of Tax -
Ebit $103M
Ebitda $110M
Net Income $89M

KRYS News

KRYS Profile

Krystal Biotech Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Krystal Biotech, Inc. is a clinical-stage biotechnology company based in Pittsburgh, Pennsylvania, focused on advancing redosable gene therapies for rare genetic diseases. Utilizing its proprietary Gene Delivery System and a strong pipeline of innovative therapies, the company seeks to provide durable solutions that enhance patient outcomes where few options exist. With a strategic emphasis on addressing significant unmet medical needs, Krystal Biotech is poised to become a transformative player in the biotechnology landscape, presenting a compelling opportunity for investors seeking exposure to cutting-edge medical advancements.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+52.76%
$1.61
VINE
+10.76%
$0.39
AMZE
+28.66%
$0.50
IPG
-1.95%
$24.57
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
BITF
+11.80%
$3.46
TLRY
-19.80%
$0.82
ADAP
-15.14%
$0.05
INTC
+7.72%
$39.65
BYND
-0.98%
$1.01
SOND
-23.45%
$0.12
WBD
+4.00%
$23.88
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
RUBI
-18.08%
$0.17
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+14.79%
$0.28
AGNC
+1.53%
$10.56
CLSK
+14.57%
$15.41
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
ONMD
+45.07%
$2.06
SNAP
-0.01%
$7.60
ASST
+0.88%
$1.14
PCG
+1.78%
$16.01
INHD
-7.36%
$0.20
AFMD
-34.94%
$0.18
ADTX
+18.78%
$3.72
CAN
+0.75%
$0.92
NVTS
+3.86%
$8.34
CHR
-4.18%
$0.04
KWM
+11.25%
$0.73
BMNU
+14.89%
$8.64
RIOT
+3.96%
$14.96
GRYP
-10.38%
$1.38
CIFR
+8.28%
$20.73
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
GPUS
-7.35%
$0.30
TEVA
+5.32%
$26.32
RXRX
+0.91%
$4.41
TSLA
+0.31%
$427.94
KDLY
+7.20%
$0.49
DEFT
+10.43%
$1.53
IBRX
+11.50%
$2.37
MARA
+6.70%
$11.85
ONDS
-3.43%
$7.95
WULF
+5.18%
$15.61
GOOGL
-0.34%
$318.85
IREN
-0.44%
$48.23
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
NIO
+0.64%
$5.49
SMX
+166.32%
$46.34
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
CRCL
+10.93%
$80.58
PLUG
+1.76%
$2.01
GRAB
+2.67%
$5.46
AG
+12.27%
$15.16
GOOG
-0.73%
$317.92
BTG
+2.92%
$4.60
F
+1.06%
$13.33
SOFI
+2.47%
$29.19
KO
+0.37%
$72.88
VALE
+0.63%
$12.59
C
+1.31%
$102.50
CRCA
+22.96%
$4.52
NEHC
+8.33%
$5.07
DVLT
-2.58%
$2.07
COMP
-0.76%
$10.42
CDE
+6.02%
$17.16
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
URBN
+13.54%
$77.56
WIT
-0.37%
$2.69
AMD
+0.90%
$216.17
ZIM
+0.97%
$19.70
CRCG
+20.69%
$2.83
AMC
+6.95%
$2.46
PLTR
+0.77%
$167.05
MPW
+2.12%
$5.77
MSTR
+2.37%
$179.82
AMZN
+1.25%
$232.04
IVP
-7.66%
$0.12
TMC
+10.72%
$6.45
ABVE
+15.58%
$3.04
SNDK
+3.75%
$223.12
NGD
+5.42%
$8.26
VSA
-6.74%
$0.11
PFE
+0.19%
$25.76
RIVN
+4.41%
$16.89
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+52.76%
$1.61
VINE
+10.76%
$0.39
AMZE
+28.66%
$0.50
IPG
-1.95%
$24.57
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
BITF
+11.80%
$3.46
TLRY
-19.80%
$0.82
ADAP
-15.14%
$0.05
INTC
+7.72%
$39.65
BYND
-0.98%
$1.01
SOND
-23.45%
$0.12
WBD
+4.00%
$23.88
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
RUBI
-18.08%
$0.17
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+14.79%
$0.28
AGNC
+1.53%
$10.56
CLSK
+14.57%
$15.41
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
ONMD
+45.07%
$2.06
SNAP
-0.01%
$7.60
ASST
+0.88%
$1.14
PCG
+1.78%
$16.01
INHD
-7.36%
$0.20
AFMD
-34.94%
$0.18
ADTX
+18.78%
$3.72
CAN
+0.75%
$0.92
NVTS
+3.86%
$8.34
CHR
-4.18%
$0.04
KWM
+11.25%
$0.73
BMNU
+14.89%
$8.64
RIOT
+3.96%
$14.96
GRYP
-10.38%
$1.38
CIFR
+8.28%
$20.73
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
GPUS
-7.35%
$0.30
TEVA
+5.32%
$26.32
RXRX
+0.91%
$4.41
TSLA
+0.31%
$427.94
KDLY
+7.20%
$0.49
DEFT
+10.43%
$1.53
IBRX
+11.50%
$2.37
MARA
+6.70%
$11.85
ONDS
-3.43%
$7.95
WULF
+5.18%
$15.61
GOOGL
-0.34%
$318.85
IREN
-0.44%
$48.23
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
NIO
+0.64%
$5.49
SMX
+166.32%
$46.34
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
CRCL
+10.93%
$80.58
PLUG
+1.76%
$2.01
GRAB
+2.67%
$5.46
AG
+12.27%
$15.16
GOOG
-0.73%
$317.92
BTG
+2.92%
$4.60
F
+1.06%
$13.33
SOFI
+2.47%
$29.19
KO
+0.37%
$72.88
VALE
+0.63%
$12.59
C
+1.31%
$102.50
CRCA
+22.96%
$4.52
NEHC
+8.33%
$5.07
DVLT
-2.58%
$2.07
COMP
-0.76%
$10.42
CDE
+6.02%
$17.16
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
URBN
+13.54%
$77.56
WIT
-0.37%
$2.69
AMD
+0.90%
$216.17
ZIM
+0.97%
$19.70
CRCG
+20.69%
$2.83
AMC
+6.95%
$2.46
PLTR
+0.77%
$167.05
MPW
+2.12%
$5.77
MSTR
+2.37%
$179.82
AMZN
+1.25%
$232.04
IVP
-7.66%
$0.12
TMC
+10.72%
$6.45
ABVE
+15.58%
$3.04
SNDK
+3.75%
$223.12
NGD
+5.42%
$8.26
VSA
-6.74%
$0.11
PFE
+0.19%
$25.76
RIVN
+4.41%
$16.89
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.